Giulia Tositti

1.0k total citations
28 papers, 607 citations indexed

About

Giulia Tositti is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Giulia Tositti has authored 28 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Giulia Tositti's work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (9 papers). Giulia Tositti is often cited by papers focused on Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (9 papers). Giulia Tositti collaborates with scholars based in Italy, United Kingdom and Vietnam. Giulia Tositti's co-authors include Fausto de Lalla, Paolo Fabris, Annarosa Floreani, Luca Lazzarini, Diego Vergani, C. Betterle, Maria Teresa Giordani, Vinicio Manfrin, Vincenzo Baldo and Corrado Betterle and has published in prestigious journals such as Diabetes Care, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Giulia Tositti

27 papers receiving 582 citations

Peers

Giulia Tositti

EPIDE

HEPAT

PHEOH

GENET

Marcello Piazza Italy

J.‐J. Lefrère France

Grazia Tosone Italy

José López‐Aldeguer Spain

Lindsay Mollison Australia

E. Minola Italy

A H Mohsen United Kingdom

Yvonne Higgins United States

Schmid Switzerland

RA Kaslow United States

Marcello Piazza Italy

Giulia Tositti

432 ×1.3

EPIDE

451 ×1.7

HEPAT

300 ×1.8

65 ×0.7

PHEOH

20 ×0.2

GENET

Citations per year, relative to Giulia Tositti Giulia Tositti (= 1×) peers Marcello Piazza

Countries citing papers authored by Giulia Tositti

Since Specialization

Citations

This map shows the geographic impact of Giulia Tositti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Tositti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Tositti more than expected).

Fields of papers citing papers by Giulia Tositti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Tositti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Tositti. The network helps show where Giulia Tositti may publish in the future.

Co-authorship network of co-authors of Giulia Tositti

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Tositti. A scholar is included among the top collaborators of Giulia Tositti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Tositti. Giulia Tositti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fabris, Paolo, Vincenzo Baldo, Tatjana Baldovin, et al.. (2008). Changing Epidemiology of HCV and HBV Infections in Northern Italy. Journal of Clinical Gastroenterology. 42(5). 527–532. 65 indexed citations

Cicconi, Paola, Alessandro Cozzi‐Lepri, Andrew Phillips, et al.. (2007). Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?. AIDS. 21(5). 599–606. 27 indexed citations

Fabris, Paolo, Giulia Tositti, Maria Teresa Giordani, et al.. (2006). Assessing patients’ understanding of hepatitis C virus infection and its impact on their lifestyle. Alimentary Pharmacology & Therapeutics. 23(8). 1161–1170. 18 indexed citations

Tommasi, Anna, Paolo Fabris, I. Carderi, et al.. (2006). Lack of Higher Frequency of the Chemokine Receptor 5-??32/??32 Genotype in Hepatitis C. Journal of Clinical Gastroenterology. 40(5). 440–443. 4 indexed citations

Tositti, Giulia, Mario Rassu, Paolo Fabris, et al.. (2005). Chlamydia pneumoniae infection in HIV‐positive patients: prevalence and relationship with lipid profile. HIV Medicine. 6(1). 27–32. 9 indexed citations

Lazzarini, Luca, et al.. (2005). Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. Journal of Infection. 51(5). 383–389. 79 indexed citations

Murri, Rita, Alessandro Cozzi Lepri, Paola Cicconi, et al.. (2005). Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(1). 23–30. 41 indexed citations

Fabris, Paolo, et al.. (2004). Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People. Current Pharmaceutical Design. 10(17). 2111–2122. 2 indexed citations

Fabris, Paolo, Annarosa Floreani, Giulia Tositti, et al.. (2003). Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Alimentary Pharmacology & Therapeutics. 18(6). 549–558. 88 indexed citations

10.

Fabris, Paolo, Giulia Tositti, Maria Teresa Giordani, et al.. (2003). Prevalence and clinical significance of circulating cryoglobulins in HIV‐positive patients with and without Co‐infection with hepatitis C virus. Journal of Medical Virology. 69(3). 339–343. 21 indexed citations

11.

Fabris, Paolo, David Brown, Giulia Tositti, et al.. (2003). Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. Journal of Clinical Virology. 29(3). 160–166. 53 indexed citations

12.

Fabris, Paolo, Alberto Pilotto, L. Bozzola, et al.. (2002). Serum pepsinogen and gastrin levels in HIV‐positive patients: relationship with CD4+ cell count and Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 16(4). 807–811. 10 indexed citations

13.

Lazzarini, Luca, et al.. (2002). Three-Times Weekly Teicoplanin in the Outpatient Treatment of Acute Methicillin-Resistant Staphylococcal Osteomyelitis: A Pilot Study. Journal of Chemotherapy. 14(1). 71–75. 11 indexed citations

14.

Tramarin, Andrea, Silvia Sartorelli, Giulia Tositti, et al.. (2002). The Application of Cost Effectiveness Analysis to Derive a Formulary for Urinary Tract Infections. Journal of Chemotherapy. 14(2). 166–174. 2 indexed citations

15.

Tositti, Giulia. (2002). Liver injury during gastroenteritis in adults: a retrospective study in 727 cases. The American Journal of Gastroenterology. 97(2). 487–488. 4 indexed citations

16.

Fabris, Paolo, et al.. (2000). Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases. European Journal of Obstetrics & Gynecology and Reproductive Biology. 93(1). 71–75. 9 indexed citations

17.

Romanò, Luisa, Paolo Fabris, Elisabetta Tanzi, et al.. (2000). GBV-C/hepatitis G virus in acute nonA–E hepatitis and in acute hepatitis of defined aetiology in Italy. Journal of Medical Virology. 61(1). 59–59. 4 indexed citations

18.

Fabris, Paolo, L. Bozzola, Mara Biasin, et al.. (1999). Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN. Journal of Gastroenterology. 34(3). 345–350. 14 indexed citations

19.

Fabris, Paolo, Mara Biasin, P. Benedetti, et al.. (1999). High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no Evidence of HCV transmission among sexual partners. Infection. 27(2). 86–91. 33 indexed citations

20.

Fabris, Paolo, Mara Biasin, Luisa Romanò, et al.. (1998). HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C. Infection. 26(5). 283–287. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact